Smart Drug Design
EMOVIAR is designing and developing Innovative Drug Product Formulation.
Our Approach
- Identify unmet medical or commercial needs
- Brainstorming technical solutions and features
- Check patentability and define FTO
- Perform lab-scale technical trials to support successful platform-patent application
- Partner with licensee for specific projects
- Provide full development service or support
- Support filing and manufacturing transfer
- Marketing and distribution by licensee
It's all about being S M A R T
'S' Simple
Robust and Reproducible
'M' Multifaceted
Different Aspects and Features
At vero eos
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
Takima sanctus
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
Tempor invidunt
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
Accusam justo
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
Smart Drug Design
EMOVIAR is designing and developing Innovative Drug Product Formulation
Our Approach
- Identify unmet medical or commercial needs
- Brainstorming technical solutions and features
- Check patentability and define FTO
- Perform lab-scale technical trials to support successful platform-patent application
- Partner with licencee for specific projects
- Provide full development service or support.
- Support filing and manufacturing transfer
- Marketing and distribution by licencee
=> Not less than striking a STAR
S = Simple
Robust and Reproducible
M = Multifaceted
Different Aspects and Features
A = Amazing
Beyond Imagination and Patentable
R = Reliable
Good Quality and Performance
T = Targeted
Ready for Tailored Therapy
Current Technologies
1. LiquiSRS
Solid Oral Dosage Form enabeling Modified Release Formulations for low soluble API. Basic Patent for the IP targeting a wide range of API and Indications got filed in April 2023.
© copyrights: all rights reserved
Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen
Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.